Opinion: Stop asking if AI is good for medicine

A commentary published by STAT News on August 6 argues against treating “Is AI good for medicine?” as a single, answerable question. According to the piece’s framing, broad verdicts of this kind obscure more than they reveal, since they lump together tools with very different purposes, evidence bases, and risks under one heading.

The commentary contends that useful evaluation has to happen at the level of specific applications rather than the technology as a whole. Tools intended to summarize clinical notes, flag possible sepsis, or transcribe patient visits face different questions about accuracy, workflow fit, and harm if they fail. Collapsing these into one debate about whether “AI” belongs in medicine, the piece suggests, makes it harder to separate uses that are working from those that are not.

The author warns that this overgeneralization carries a practical cost. When adoption decisions are driven by sweeping optimism or sweeping skepticism rather than tool-by-tool assessment, health systems risk either rushing forward with unproven applications or holding back approaches that have already shown they work.

The piece does not offer a blanket recommendation for or against AI adoption in clinical settings. Its argument is procedural: that the field needs finer-grained scrutiny, tool by tool, rather than a single up-or-down judgment applied across the board.